Drug recall · February 7, 2018
Cefuroxime recall
Why: Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cefuroxime, Ophthalmic Solution for Injection, 10 mg/mL, 0.3 mL single-use syringe. This is a Compounded Drug, Hospital & Office Use Only, Not for Resale. Fagron Sterile Services/JCB Laboratories, 7335 W. 33rd St. N., Wichita, KS 67205
- Lots / codes
Lot #: C274-000002725, BUD 1/21/2018; C274-000002790, BUD 1/28/2018; C274-000002989, BUD 2/13/2018; C274-000003008, BUD 2/14/2018; C274-000003077, BUD 2/20/2018
- Quantity
- 6,510 syriges
- Company
- JCB Laboratories LLC, Wichita, KS
- Distribution
- Nationwide within USA
- Initiated
- January 24, 2018 · Voluntary: Firm initiated
- Classified
- January 30, 2018
- Reported
- February 7, 2018
- Ended
- August 3, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefuroxime
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.